Once a celebrated Harvard nanoscience professor, Charles Lieber, convicted in the US for false statements tied to Chinese ...

The former head of Harvard chemistry department defects to China – giving them the edge in the global race to develop the ...

A US company has tested a brain implant in four Chinese patients in Shanghai, a rare sign of cooperation as the two countries compete to develop the most advanced neurotechnology.

Earlier this week, the United States Food and Drug Administration (FDA) approved a human trial for a blueberry-sized brain ...

A new research paper argues that emerging brain–computer interface (BCI) technologies are not just medical tools but ...

An American scientist convicted of lying to U.S. authorities about payments from China while he was at Harvard University has ...

Driven by a strategic influx of venture capital and robust policy tailwinds, BCI is fast graduating from academic curiosity ...

Convicted ex‑Harvard professor Charles Lieber is now leading an i‑BRAIN lab in Shenzhen with advanced fabrication and primate ...

Former Harvard chair Charles Lieber has relocated to China following his U.S. conviction to lead a state-backed ...

Precision Neuroscience Corporation (Precision), a leader in brain–computer interface (BCI) technology, and researchers at the University of Chicago Medicine (UChicago Medicine) have launched a ...

MintNeuro and Motif Neurotech today announced plans to accelerate the clinical availability of therapeutic brain-computer ...

MintNeuro, a pioneer of scalable, low-power semiconductor technology for neural implant applications, and Motif Neurotech, a therapeutic brain-computer interface (BCI) company developing miniature ...